| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A clinician’s guide for developing a prediction model: a case study using real-world data of patients with castration-resistant prostate cancer
|
Veen, Kevin M.
|
|
|
146 |
8 |
p. 2067-2075
|
artikel
|
| 2 |
Breast cancer: are long-term and intermittent endocrine therapies equally effective?
|
Engel, Jutta
|
|
|
146 |
8 |
p. 2041-2049
|
artikel
|
| 3 |
Cancer risks in patients with vitiligo: a Mendelian randomization study
|
Wen, Yaokai
|
|
|
146 |
8 |
p. 1933-1940
|
artikel
|
| 4 |
Comparison of liquid-based to tissue-based biopsy analysis by targeted next generation sequencing in advanced non-small cell lung cancer: a comprehensive systematic review
|
Esagian, Stepan M.
|
|
|
146 |
8 |
p. 2051-2066
|
artikel
|
| 5 |
Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma
|
Cui, Yuanbo
|
|
|
146 |
8 |
p. 1993-2006
|
artikel
|
| 6 |
Correction to: Sequential anti-CD19, 22, and 20 autologous chimeric antigen receptor T-cell (CAR-T) treatments of a child with relapsed refractory Burkitt lymphoma: a case report and literature review
|
Du, Juan
|
|
|
146 |
8 |
p. 2177
|
artikel
|
| 7 |
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials
|
Stahler, Arndt
|
|
|
146 |
8 |
p. 2077-2087
|
artikel
|
| 8 |
Cytoplasmic versus nuclear THR alpha expression determines survival of ovarian cancer patients
|
Ditsch, Nina
|
|
|
146 |
8 |
p. 1923-1932
|
artikel
|
| 9 |
Detection of miR-155-5p and imaging lung cancer for early diagnosis: in vitro and in vivo study
|
Zhu, Hai-Zhen
|
|
|
146 |
8 |
p. 1941-1951
|
artikel
|
| 10 |
Discovery of a transcriptomic core of genes shared in 8 primary retinoblastoma with a novel detection score analysis
|
Alvarez-Suarez, Diana E.
|
|
|
146 |
8 |
p. 2029-2040
|
artikel
|
| 11 |
Effect of aspirin use on neoadjuvant chemoradiotherapy for rectal cancer: a meta-analysis with trial sequential analysis
|
Wang, Bolin
|
|
|
146 |
8 |
p. 2161-2171
|
artikel
|
| 12 |
Enhanced cytotoxicity against solid tumors by bispecific antibody-armed CD19 CAR T cells: a proof-of-concept study
|
Thakur, Archana
|
|
|
146 |
8 |
p. 2007-2016
|
artikel
|
| 13 |
Expression of H3K4me3 and H3K9ac in breast cancer
|
Berger, Luisa
|
|
|
146 |
8 |
p. 2017-2027
|
artikel
|
| 14 |
Harvest of at least 18 lymph nodes is associated with improved survival in patients with pN0 colon cancer: a retrospective cohort study
|
Ning, Fei-Long
|
|
|
146 |
8 |
p. 2117-2133
|
artikel
|
| 15 |
IL-10 c.-592C>A (rs1800872) polymorphism is associated with cervical cancer
|
Pereira, Ana Paula Lombardi
|
|
|
146 |
8 |
p. 1971-1978
|
artikel
|
| 16 |
Is vimentin a potential prognostic factor for patients with triple-negative breast cancer?
|
Schmidt, Gilda
|
|
|
146 |
8 |
p. 2109-2116
|
artikel
|
| 17 |
Long-term small-fiber neuropathy and pain sensitization in survivors of pediatric acute lymphoblastic leukemia after stem cell transplantation
|
Ruscher, Victoria
|
|
|
146 |
8 |
p. 2143-2152
|
artikel
|
| 18 |
Melatonin: an endogenous miraculous indolamine, fights against cancer progression
|
Samanta, Saptadip
|
|
|
146 |
8 |
p. 1893-1922
|
artikel
|
| 19 |
Neoadjuvant chemotherapy improves the survival of patients with neuroendocrine carcinoma and mixed adenoneuroendocrine carcinoma of the stomach
|
Ma, Fuhai
|
|
|
146 |
8 |
p. 2135-2142
|
artikel
|
| 20 |
Selected protein expression in a new prognostic model for patients with non-muscle-invasive bladder cancer
|
Semeniuk-Wojtaś, Aleksandra
|
|
|
146 |
8 |
p. 2099-2108
|
artikel
|
| 21 |
SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis
|
Xu, Ning
|
|
|
146 |
8 |
p. 1953-1969
|
artikel
|
| 22 |
The evidence strength of a meta-analysis of aspirin for primary prevention of cancer
|
Wu, Qibiao
|
|
|
146 |
8 |
p. 2173-2175
|
artikel
|
| 23 |
The paratumoral immune cell signature reveals the potential for the implementation of immunotherapy in esophageal carcinoma patients
|
Strizova, Zuzana
|
|
|
146 |
8 |
p. 1979-1992
|
artikel
|
| 24 |
Treatment discontinuation and re-initiation of anti-PD-(L)1 agents in metastatic cancers
|
Tikkanen, Antti
|
|
|
146 |
8 |
p. 2153-2160
|
artikel
|
| 25 |
Vitamin and herbal supplements’ use among patients with advanced gastrointestinal cancers included in eight clinical trials
|
Abdel-Rahman, Omar
|
|
|
146 |
8 |
p. 2089-2097
|
artikel
|
Tijdschrift beschrijving